Harnessing regulatory T cells to establish immune tolerance

Engineered regulatory T (T-reg) cells have emerged as precision therapeutics aimed at inducing immune tolerance while reducing the risks associated with generalized immunosuppression. This Viewpoint highlights the opportunities and challenges for engineered T-reg cell therapies in treating autoimmune and other inflammatory diseases.